Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)

被引：0
|
作者：
Noro, R. [1 ]
Kobayashi, K. [2 ]
Usuki, J. [3 ]
Hosomi, Y. [4 ]
Nishitsuji, M. [5 ]
Okamoto, H. [6 ]
Ando, M. [7 ]
Hino, M. [8 ,9 ,10 ]
Hagiwara, K. [11 ]
Miyanaga, A. [1 ]
Seike, M. [1 ]
Kubota, K. [1 ]
Gemma, A. [1 ]
机构：
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Hidaka, Japan
[3] Nippon Med Sch, Musashikosugi Hosp, Dept Pulm Med, Kawasaki, Kanagawa, Japan
[4] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[5] Ishikawa Prefectural Cent Hosp, Dept Pulm Med, Kanazawa, Ishikawa, Japan
[6] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[7] Tsuboi Canc Ctr Hosp, Jizankai Med Fdn, Dept Internal Med, Fukushima, Japan
[8] Nippon Med Sch, Chiba Hokuso Hosp, Dept Pulm Med, Chiba, Japan
[9] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
[10] Nippon Med Sch, Dept Pulm Med, Chiba Hokuso Hosp, Chiba, Japan
[11] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical course of asymptomatic malignant pleural effusion in non-small cell lung cancer patients A multicenter retrospective study
    Roh, Jiyeon
    Ahn, Hyo Yeong
    Kim, Insu
    Son, Ju Hyeong
    Seol, Hee Yun
    Kim, Mi Hyun
    Lee, Min Ki
    Eom, Jung Seop
    MEDICINE, 2021, 100 (19) : E25748
  • [42] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
    Shibaki, Ryota
    Murakami, Shuji
    Shinno, Yuki
    Matsumoto, Yuji
    Goto, Yasushi
    Kanda, Shintaro
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Motoi, Noriko
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (04) : 815 - 822
  • [43] Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion
    Li, Tianyuan
    Tian, Panwen
    Huang, Qin
    Zeng, Hao
    Wei, Qi
    Li, Yalun
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11): : 1158 - 1168
  • [44] PHASE II STUDY OF BEVACIZUMAB PLUS CBDCA/PAC AS FIRST LINE CHEMOTHERAPY FOR NON-SQ NSCLC WITH MALIGNANT PLEURAL EFFUSION
    Tamiya, M.
    Tamiya, A.
    Yasue, T.
    Suzuki, H.
    Okamoto, N.
    Okishio, K.
    Asami, K.
    Kawaguchi, T.
    Atagi, S.
    Hirashima, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [45] Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)
    Takemoto, Shinnosuke
    Fukuda, Minoru
    Ogata, Ryosuke
    Senju, Hiroaki
    Sugasaki, Nanae
    Nakatomi, Katsumi
    Tomono, Hiromi
    Suyama, Takayuki
    Sasaki, Eisuke
    Matsuo, Midori
    Akagi, Kazumasa
    Hayashi, Fumiko
    Dotsu, Yosuke
    Ono, Sawana
    Honda, Noritaka
    Taniguchi, Hirokazu
    Gyotoku, Hiroshi
    Ikeda, Takaya
    Nagashima, Seiji
    Soda, Hiroshi
    Kinoshita, Akitoshi
    Mukae, Hiroshi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10)
  • [46] PHASE II TRIAL OF BEVACIZUMAB PLUS DOCETAXEL IN PATIENTS WITH PREVIOUSLY TREATED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Ohyanagi, F.
    Kudo, K.
    Yanagitani, N.
    Horiike, A.
    Horai, T.
    Nishio, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 441 - 442
  • [47] Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515
    Yoshida, Kimihide
    Sugiura, Takahiko
    Takifuji, Nobuhide
    Kawahara, Masaaki
    Matsui, Kaoru
    Kudoh, Shinzoh
    Takada, Minoru
    Fukuoka, Masahiro
    Ariyoshi, Yutaka
    Fukuda, Haruhiko
    Saijo, Nagahiro
    LUNG CANCER, 2007, 58 (03) : 362 - 368
  • [48] Relationship of clinicopathological characteristics, EGFR genotyping and prognosis in non-small cell lung cancer patients with malignant pleural effusion
    Zhang, J.
    Zhou, Z. S.
    Su, Y. C.
    Yu, T. Q.
    ANNALS OF ONCOLOGY, 2019, 30
  • [49] Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion
    Koyama, N.
    Watanabe, Y.
    Iwai, Y.
    Miwa, C.
    Nagai, Y.
    Aoshiba, K.
    Nakamura, H.
    NEOPLASMA, 2018, 65 (01) : 132 - +
  • [50] Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study
    Qi Wei
    Taibing Deng
    Junhua Wu
    Hao Zeng
    Chang Qi
    Sihan Tan
    Yuanyuan Zhang
    Qin Huang
    Xin Pu
    Weiguo Xu
    Weimin Li
    Panwen Tian
    Yalun Li
    BMC Cancer, 24
12345